Form 8K 2014.08.27

0001348324-14-000057.txt : 20140827 0001348324-14-000057.hdr.sgml : 20140827 20140827160503 ACCESSION NUMBER: 0001348324-14-000057 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20140827 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20140827 DATE AS OF CHANGE: 20140827 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LDR HOLDING CORP CENTRAL INDEX KEY: 0001348324 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 203933262 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36095 FILM NUMBER: 141068499 BUSINESS ADDRESS: STREET 1: 13785 RESEARCH BOULEVARD STREET 2: SUITE 200 CITY: AUSTIN STATE: TX ZIP: 78750 BUSINESS PHONE: 512-344-3333 MAIL ADDRESS: STREET 1: 13785 RESEARCH BOULEVARD STREET 2: SUITE 200 CITY: AUSTIN STATE: TX ZIP: 78750 8-K 1 form8k.htm FORM 8-K Form 8K 2014.08.27

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_____________________

FORM 8-K

_____________________

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): August 27, 2014

LDR HOLDING CORPORATION

(Exact Name of Registrant as Specified in its Charter)

_____________________



Delaware (State or Other Jurisdiction of Incorporation)	001-36095 (Commission File Number)	20-3933262 (I.R.S. Employer Identification No.)
13785 Research Boulevard, Suite 200 Austin, Texas (Address of Principal Executive Offices)		78750 (Zip Code)
Registrant’s telephone number including area code: (512) 344-3333
No change since last report (Former Name or Address, if Changed Since Last Report)

_____________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Section 1 - Registrant's Business and Operations

Item 1.01 Entry into a Material Definitive Agreement.

On August 27, 2014, LDR Médical, S.A.S. (“LDR Médical”), a wholly owned subsidiary of LDR Holding Corporation (the “Company”), entered into an amendment (the “Amendment”) with Invibio Ltd. to the Supply Agreement, dated January 31, 2003, as amended, to extend the term of such agreement through October 1, 2014.

The foregoing description of the Amendment does not purport to be complete and is subject to and qualified in its entirety by reference to the full text of the Amendment, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Section 9 - Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits.



Exhibit Number		Description
10.1		Amendment, dated August 27, 2014, to Supply Agreement, by and between LDR Médical, S.A.S and Invibio Ltd.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.



			LDR HOLDING CORPORATION


Dated:	August 27, 2014	By:	/s/ Scott Way
			Scott Way
			Executive Vice President, General Counsel, Compliance Officer and Secretary

EXHIBIT INDEX



Exhibit Number		Description
10.1		Amendment, dated August 27, 2014, to Supply Agreement, by and between LDR Médical, S.A.S and Invibio Ltd.

EX-10.1 2 ex-101.htm EX-10.1 Exhibit 10.1 2014.08.27

EXHIBIT 10.1



	Invibio^® biomedical solutions Invibio LTD Technology Centre Hillhouse International Thornton Cleveleys. Lancashire FY5 4QD UK Tel. +44 (0)1253 866812 Tel +44 (0)1253 851458 info@invibio.com www.invibio.com

22^nd August 2014

LDR Medical

Technopole de L'Aube

BP 2-10 902

Troyes cedex 9

France

Dear Sirs,

Letter of Amendment in respect of Supply Agreement between Invibio Ltd. and LDR Medical dated January 31 2003 and subsequent Amendments (the "Agreement").

Following our discussions we are writing to confirm that pursuant to section 27.1 of the Agreement we have agreed to make the following amendment to the Agreement:


1.	Clause 3 of the Agreement shall be amended such that the Term of the Agreement shall be extended until the 1^st of October 2014 inclusive.

All capitalized terms used in this Letter shall have the same meaning as when used in the Agreement.

This letter and all matters arising from or connected with it are governed by English Law.

Except as expressly provided in this letter of amendment, all other terms, conditions, and provisions of the Agreement shall continue in full force and effect as provided therein.




/s/ Jonathan Parr		/s/ Eric Vigneron
An authorised signatory for and on behalf of Invibio, Ltd.		An authorised signatory for and on behalf of LDR Medical

Name: Jonathan Parr		Name: Eric Vigneron
Position: Financial Controller		Position: Deputy General Manager
Date: August 27, 2014		Date: August 27, 2014